Skip to Main Content

Paper Details

Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial.
Clin Lung Cancer
1
2023
Author NameAffiliation
Catherine KlersyFondazione IRCCS Policlinico San Matteo
  • 1 - 1

Datasets

Release 1.2